Mankind Pharma Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Mankind Pharma Ltd. on BSE

Load latest

Mankind Pharma Ltd.

11 Aug 2025

2258.90

0.76%

Company Update

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation about the upcoming Investor Meet of Mankind Pharma Limited

pdf

Mankind Pharma Ltd.

08 Aug 2025

2258.90

0.76%

Company Update

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

We wish to inform you that the shareholders of the Company, at the 34th Annual General Meeting held on Thursday August 7, 2025 has considered and approved the appointment of M/s. Amit Gupta & Associates as Secretarial Auditors of the Company. Said appointment was earlier considered and approved by the Board of Directors of the Company in its meeting held on May 21, 2025.

pdf

Mankind Pharma Ltd.

08 Aug 2025

2258.90

0.76%

AGM

Mankind Pharma Ltd - 543904 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Please find enclosed herewith voting results and Scrutinizers Report pertaining to 34th Annual General Meeting of the Company held on August 7, 2025.

pdf

Mankind Pharma Ltd.

07 Aug 2025

2258.90

0.76%

AGM

Mankind Pharma Ltd - 543904 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Please find enclosed herewith proceedings of the 34th Annual General Meeting of the Company held on August 7, 2025 through Video Conferencing.

pdf

Mankind Pharma Ltd.

06 Aug 2025

2258.90

0.76%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find enclosed herewith transcript of the Investor Conference Call for Q1 FY26 held on August 1, 2025

pdf

Mankind Pharma Ltd.

03 Aug 2025

2258.90

0.76%

Company Update

Mankind Pharma Ltd - 543904 - Intimation For Submission Of Application For Reclassification

BSE India

We wish to inform you that the Company has today, i.e. August 3, 2025, submitted application for reclassification of Ayushi and Poonam Estates LLP from the "Promoter and Promoter Group" Category to "Public" Category.

pdf

Mankind Pharma Ltd.

01 Aug 2025

2258.90

0.76%

Company Update

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find attached Newspaper Publication of unaudited financial results for the quarter ended on June 30, 2025

pdf

Mankind Pharma Ltd.

01 Aug 2025

2258.90

0.76%

Earnings Call

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Investor Conference Call for Q1 & FY26 - Audio Recording

pdf

Mankind Pharma Ltd.

01 Aug 2025

2258.90

0.76%

Mankind Pharma Results Earnings Call for Q1FY26

Conference Call with Mankind Pharma Management and Analysts on Q1FY26 Performance and Outlook. Listen to the full earnings transcript.

audio

Mankind Pharma Ltd.

31 Jul 2025

2258.90

0.76%

Company Update

Mankind Pharma Ltd - 543904 - Announcement Under Regulation 30- TDS Communication To The Shareholders.

BSE India

Please find attached the Specimen of the Communication sent to the shareholders regarding the deduction of tax to be deducted on the Interim Dividend declared by the Board of Directors for FY 2025-26.